Training group | Validating group | Healthy donors | Reverse validating group | Total patients | |||
---|---|---|---|---|---|---|---|
HCV Treatment Response | 5 NR | 4 SVR | 5 NR | 5 SVR | NA | NA | n=19 |
Caucasian | n=5 | n=4 | n=5 | n=5 | n=7 | n=8 | n=34 |
HCV genotype 1 | n=5 | n=4 | n=5 | n=5 | NA | n=8 | n=28 |
HCV Treatment naïve | n=5 | n=4 | n=5 | n=5 | n=7 | n=8 | n=34 |
Age mean±SD | 44,2±18,36 | 32,3±14,43 | 60±7,8 | 51±6,4 | 45±4 | 48±16 | n=34 |
Viral Load mean ±SD | 3256750 ± 2672345,209 | 646000 ± 234921,3 | 3076667 ± 2438080 | 1506000 ± 1887003 | NA | 1908796 ± 1457469 | n=27 |
ALT mean±SD | 90,25±41,83 | 48±7 | 66 ± 55 | 116±90,23 | NA | 72±65 | n=27 |
F1 | n=2 | n=2 | n=0 | n=2 | NA | n=2 | n=8 |
F2 | n=0 | n=1 | n=0 | n=1 | NA | n=2 | n=4 |
F3 | n=0 | n=1 | n=3 | n=1 | NA | n=3 | n=9 |
F4 | n=3 | n=0 | n=2 | n=1 | NA | n=3 | n=9 |
Total patients | n=9 | n=10 | n=7 | n=8 | n=34 |